A 55-year-old woman with stable angina pectoris who had undergone elective coronary catheterization five years ago, no coronary artery disease had been reported at that time. Recent noninvasive stress testing was performed and the result was positive. Coronary angiography was repeated by using iodinated contrast medium. At catheterization, no angiographically significant coronary stenoses was found. About 36 hours after coronary angiography she presented to the emergency department for swelling of face and throat bilaterally. Her parotid glands were diffusely and symmetrically enlarged to twice the normal size and glands were firm and non-tender. This case had taken iodinated contrast medium before and she had the same symptoms. So she might be an example of recurrent parotitis caused by repeated iodide exposure. (Hong Kong j.emerg.med. 2011;18:421-423) 55 36
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Case report
A 55-year-old woman referred to our hospital by her primary care physician after the onset of stable angina pectoris. She had hyperlipidaemia, hypertension and a family history of coronary heart disease. She had undergone elective cardiac catheterisation five years ago and no coronary artery disease was detected. She was taking acetylsalicylic acid at a dose of 100 mg/day and ramipril at a dose of 10 mg/day. Physical examination was normal. An electrocardiogram revealed a sinus rate of 89 beats per minute and a 1 mm ST-segment depression in leads V4, V5, V6. An exercise stress testing was performed. During exercise stress testing, horizontal ST-segment depression of 2 mm together with a slight chest discomfort was developed and the test was recorded as positive. The patient underwent elective coronary angiography by using iodinated contrast medium that contains iopamidol (Iopamiro-300) which is a non-ionic iodinated positive contrast agent used in contrast radiography. Iopamidol formulations are stable, aqueous, sterile, and n o n p y r o g e n i c s o l u t i o n s f o r i n t r a v a s c u l a r administration. Each mL of Iopamiro-300 (lopamidol Injection 61.2%) provides 612 mg iopamidol with 1 mg tromethamine and 0.33 mg edetate calcium disodium. The solution contains approximately 0.043 mg (0.002 mEq) sodium and 300 mg organically bound iodine per mL. A total of 110 ml of iodinated contrast media (ICM) was used. Pre-contrast medication wasn't performed to patient before coronary angiography. At angiography, there were minimal atherosclerotic plaques in her coronary arteries.
About 36 hours later following coronary angiography, she presented to the emergency department for symptoms of pain and swelling of face and throat bilaterally ( Figures  1 & 2) . The temperature was 36.5°C. An inpatient evaluation by the otorhinolaryngology service showed that her parotid glands were diffusely and symmetrically enlarged to twice the normal size and glands were firm and nontender. However, there was no symptoms and physical examination findings for the other organs e.g. submandibular gland, lacrimal gland, thyroid, we performed the thyroid functional tests and that was normal. The laboratory examination showed minimally WBC elevation (10,300 per cubic milimeter) and a CRP less than 10 mg/dL (8.5 mg/dL). The values of her creatinine was 0.8 mg/dL at the admission and that was 0.7 mg/dL 3 days later after admission. On ultrasonographic examination, there were two nodules (4 x 5 mm and 3 x 5 mm) in right parotid gland and a few small adenoids in left parotid gland and skin. The parotid gland size were not reported. Also subcutaneous tissues were thickened consistent with oedema. Also, she had similar symptoms after her first coronary angiography. A single intravenous dose of 20 mg dexametazone and 600 mg ibuprofen twice a day for two week was administered. She was followed for three days in cardiology service and has remained asymptomatic after discharge. Her symptoms resolved three days after the cardiology department attendance.
Discussion
The term iodide mumps was defined by Sussmen and Miller in 1956 who first described a sialadenitis complicating the intravenous administration of iodinated contrast media (ICM). 1 After intravenous administration, the iodinated contrast disperses almost completely in the intravascular space. Majority of it is eliminated by the kidney, in case of high plasma concentration, together with renal impairment, it can be eliminated via alternative pathways like the salivary glands where it exerts a direct toxic effect. 2 It has been reported that parenteral iodide administration in hamsters and rats had been shown to induce oedema, cellular necrosis, and inflammation of the salivary glands. 3, 4 However, most of the sialadenitis occurring with ICM are described in patients who do not have renal impairment, 5 like our patient. Consequently, the reaction is mostly a toxic result because of contrast of high blood level.
A review of literature based on case reports involving 30 patients reveals that the onset of iodide mumps happens within a few hours up to 5 days. 6 In our case, the symptoms has initiated within 36 hours. In contrast to our case, submandibular glands were involved (71%) more than parotid glands.
To our best knowledge, a life-threating reaction has never been reported for this complication. The facial nerve palsy, requiring decompression, was the most severe complication that has been reported so far. 7 As with our case, previous studies also reported that repeat contrast medium administration produced recurrence of iodide induced mumps. 3, [7] [8] [9] [10] The treatment of iodideinduced sialadenitis is different from suppurative sialadenitis. Suppurative sialadenitis should be precisely treated with antibiotics and frequently requires surgical drainage; at the same time, iodide induced sialadenitis generally resolves after supportive treatment alone. Antihistamines, anti-inflammatory drugs, and corticosteroids have been used to treat iodide-induced sialadenitis. In our case, a single intravenous dose of 20 mg dexametazone and 600 mg ibuprofen twice a day for two week was administered.
Conclusion
Parotitis may develop after iodinated contrast coronary angiography. The diagnosis should be suspected when patients present with neck swelling after the procedure. Anti-inflammatory agents are the choice for the treatment
